论文部分内容阅读
妊娠的绒毛膜肿瘤代表一种极好的生物学系统有三方面的理由:在发生学上是男性与女性的混合,有显著的化疗反应,治愈率高,并且有 hCG 的分泌;这可作为诊断、治疗鉴茯及缓解期的随访。非妊娠绒毛膜肿瘤也具有 hCG 的独特分布特点,因此内分泌测定,特别是测定 hCG 对于处理这些肿瘤起着重要的作用。但是作为一种工具,我们已加深理解其应用意义,很可能在其他肿瘤也产生此类相似特异性的物质,并以同样的方法被利用。如甲胎蛋白及癌胚抗原,它们也已作为一种方法,但没有 hCG 这样特异性。我们对于绒毛膜肿瘤的经验使之有可能进一步发展这种技术使之应用到其他肿瘤系统中去,若可靠的细胞标记器可用的话。当这种时刻到来时,我们就能期望肿瘤治疗率提高,并达到如绒毛膜肿瘤所得的那样结果。
Pregnancy, a choriocarcinoma, represents an excellent biological system for three reasons: in theory, it is a mix of males and females, with significant chemotherapeutic responses, high rates of cure, and the secretion of hCG; this can be used as a diagnosis , Treatment of Fu Fu and follow-up of remission. Non-gestational choriocarcinomas also have a unique distributional profile of hCG, and therefore endocrine assays, particularly hCG assays, play an important role in the treatment of these tumors. However, as a tool, we have deepened our understanding of its implications and are likely to generate such similar specificities in other tumors and be used in the same way. Such as alpha-fetoprotein and carcinoembryonic antigen, they have also been used as a method, but no hCG so specific. Our experience with choriocarcinoma has made it possible to further develop this technology for use in other oncological systems, if reliable cell markers are available. When this moment comes, we can expect an increase in the rate of tumor treatment, as well as the result of a choriocarcinoma.